Zismanov, Victoria <br/><br/>
Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration.  [electronic resource] 

 -  Anti-cancer drugs  Oct 2014 
 - 998-1006 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000140  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzoquinones--pharmacology<br/>Biomarkers, Tumor--metabolism<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Cell Line, Tumor--drug effects<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Endoplasmic Reticulum Stress<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Lactams, Macrocyclic--pharmacology<br/>Lung Neoplasms--metabolism<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors--pharmacology<br/>Pyrazines--pharmacology<br/>Unfolded Protein Response--drug effects